Semler Scientific Expands Bitcoin Holdings and Updates ATM Equity Offering

Semler Scientific's Strategic Move: Bitcoin and ATM Offerings

In a recent announcement that is capturing attention in both the healthcare and financial markets, Semler Scientific, Inc. (Nasdaq: SMLR) has disclosed its latest developments regarding its bitcoin (BTC) acquisitions and its at-the-market (ATM) equity offering activities. With a commitment to enhancing technologies that assist in evaluating and treating chronic diseases, Semler Scientific is also making notable strides in the digital currency arena.

Recent Bitcoin Acquisitions

Between mid-February and late April 2025, Semler Scientific has successfully acquired an additional 111 bitcoins at a total investment of $10 million, reflecting an average purchase price of $90,124 per bitcoin. These acquisitions were funded through capital raised from its ATM offerings along with available cash reserves. As of April 24, 2025, the company holds a robust total of 3,303 bitcoins valued at approximately $309.1 million based on current market evaluations, showcasing a strategic pivot towards cryptocurrency as part of its treasury management.

CEO [Name], emphasizes that “This strategy not only diversifies our assets but also fortifies our capital structure with innovative investment opportunities.”

Commitment to Equity Offerings

Running concurrently with its bitcoin purchasing strategy, Semler Scientific also operates an ATM equity offering program aimed at generating funds for various initiatives, including further investment in cryptocurrency. Earlier this year, the company entered into a Controlled Equity OfferingSM Sales Agreement with Cantor Fitzgerald & Co., which has allowed it to issue and sell shares, achieving net proceeds of around $126 million prior to the initiation of a new agreement. On April 15, 2025, Semler Scientific expanded its ATM effort with new partners, such as Barclays Capital and Canaccord Genuity, creating an opportunity for issuing up to $500 million of common stock. This new venture indicates a strong commitment to leveraging equity for growth and innovation.

Bitcoin Yield Performance

Another notable highlight is Semler's Year-to-Date bitcoin yield of 23.5%, a figure the company cites as a critical performance indicator (KPI) for assessing the efficacy of its bitcoin investment strategy. The yield is based on the ratio of its bitcoin holdings relative to the company’s assumed diluted shares outstanding, providing insights into how effectively Semler is utilizing its capital to increase shareholder value. However, it's crucial to note that while this yield presents a positive view of Semler's strategy, it is not a traditional financial metric and should be viewed in context.

The management team at Semler is excited about the current trajectory of the firm and the potential it sees in the bitcoin market. BTC yield is viewed as a tool to gauge the performance of their rigorous capital deployment strategy and effectively communicate with investors about the company’s investments.

Navigating Future Challenges

On a cautionary note, Semler Scientific acknowledges that investing in bitcoin carries inherent risks, including market volatility and external economic factors. As such, the company prepares to navigate these challenges while working to solidify its strategy in both healthcare innovation and digital currency.

Future disclosures will continue to keep investors informed about their position and strategic choices as the company seeks to maximize returns.

Ultimately, Semler Scientific is positioning itself not only as a healthcare innovator but also as a pioneer in the evolving landscape of cryptocurrency investment. This multifaceted approach is indicative of the broader shift we are witnessing across industries, where healthcare companies are increasingly looking to diversify into digital assets. Stakeholders and investors alike will be watching closely to see how these developments unfold in the coming quarters.